Related Experiment Videos
Intramuscular dexmedetomidine as premedication for general anesthesia. A comparative multicenter study
H Scheinin1, M L Jaakola, S Sjövall
1Department of Anesthesiology, Turku University Central Hospital, Finland.
Anesthesiology
|June 1, 1993
Summary
Dexmedetomidine effectively reduces preoperative anxiety and sedation needs but increases intraoperative hypotension and bradycardia. This alpha-2 agonist shows promise as a preanesthetic agent, though careful monitoring is required.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Dexmedetomidine is a potent and selective alpha-2 agonist with potential as a preanesthetic agent.
- Alpha-2 agonists modulate sympathetic nervous system activity.
Purpose of the Study:
- To evaluate the efficacy and safety of dexmedetomidine as a preanesthetic agent.
- To compare dexmedetomidine with midazolam and fentanyl for preanesthetic medication.
Main Methods:
- Randomized, double-blind study in 192 patients undergoing elective surgery.
- Comparison of intramuscular dexmedetomidine (DEXPLA, DEXFENT) versus intramuscular midazolam and intravenous fentanyl (MIDFENT).
- Anesthesia maintained with sevoflurane, N2O/O2, and fentanyl as needed.
Main Results:
- Dexmedetomidine and midazolam provided comparable preoperative sedation and anxiolysis.
- Dexmedetomidine groups required significantly less intraoperative fentanyl.
- Increased incidence of intraoperative hypotension and bradycardia observed in dexmedetomidine groups.
Conclusions:
- Pretreatment with dexmedetomidine is efficacious for preanesthesia.
- Dexmedetomidine significantly increases the risk of intraoperative hypotension and bradycardia.
- Further research needed to optimize dexmedetomidine use in anesthesia.